Loading clinical trials...
Loading clinical trials...
"Phase II/Pilot Study of 2nd Generation Anti-CEA Esigner T Cells in Adenocarcinomas"
Conditions
Interventions
Gene Modified T Cells
Locations
1
United States
Roger Williams Medical Center
Providence, Rhode Island, United States
Start Date
October 1, 2012
Primary Completion Date
October 1, 2016
Completion Date
August 1, 2017
Last Updated
June 14, 2016
NCT07236021
NCT04958434
NCT02303990
Lead Sponsor
Roger Williams Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions